Diabetes Research and Clinical Practice
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q2 | 73.0% | 1.690 | Q1 | 93.5% |
| 2024 | 7.4 | Q1 | 91.2% | 1.537 | Q1 | 92.6% |
| 2023 | 6.1 | Q1 | 87.7% | 1.340 | Q1 | 91.2% |
| 2022 | 5.1 | Q2 | 75.4% | 1.634 | Q1 | 94.0% |
| 2021 | 8.2 | Q1 | 87.7% | 1.677 | Q1 | 94.3% |
| 2020 | — | — | 1.605 | Q1 | 93.3% | |
| 2019 | — | — | 1.402 | Q1 | 91.7% | |
| 2018 | — | — | 1.206 | Q1 | 88.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0168-8227
ISSN
0168-8227
country
IEcoverage
1985-2026